Get the tools used by (smart)2 investors.
SP500 -0.3%DOW -0.5%FTSE 100 -0.2%NIKKEI -0.7%OIL -0.0%GOLD 1.0%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

NAV / Share Forecast Median Consensus for Assertio Therapeutics Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

ASRT: Assertio Therapeutics Inc

Assertio Holdings, Inc., a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution ...

- USD
Price
– USD
Fair Value
–
Upside
- - -
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Assertio Therapeutics Inc's NAV / Share Forecast Median Consensus:

Dec 2026Dec 2028Dec 2030Dec 2032Dec 20340
Performance Summary

    How does Assertio Therapeutics's NAV / Share Forecast Median Consensus benchmark against competitors?

    Hide this widget

    We've identified the following companies as similar to Assertio Therapeutics Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

    Assertio Therapeutics NAV / Share Forecast Median Consensus Benchmarks
    NameTickerNAV / Share Forecast Median Consensus
    Jazz Pharmaceuticals PLCNASDAQGS:JAZZ-22.42
    Prestige Consumer Healthcare IncNYSE:PBH-19.76
    Assertio Therapeutics IncNASDAQCM:ASRT-
    Supernus Pharmaceuticals IncNASDAQGM:SUPN-
    Aquestive Therapeutics IncNASDAQGM:AQST-
    Nektar TherapeuticsNASDAQCM:NKTR-
    Collegium Pharmaceutical IncNASDAQGS:COLL-
    ANI Pharmaceuticals IncNASDAQGM:ANIP-
    Amphastar PNASDAQGS:AMPH-
    Pacira Pharmaceuticals IncNASDAQGS:PCRX-
    Insmed IncNASDAQGS:INSM-
    HealthcareSECTOR:HLTH.US2.97

    Metric Usage: NAV / Share Forecast Median Consensus

    Hide this widget
    nav_share_proj_median_raw
    Slug
    number
    Datatype
    text
    Format
    current
    Default Period
    FY, Q
    Periods Supported
    Free
    Plan

    To view the full list of supported financial metrics please see Complete Metrics Listing.

    Similar Metrics

    Hide this widget

    Metrics similar to NAV / Share Forecast Median Consensus in the forecast category include:

    View Full List

    Search for metric or datapoint

    NAV / Share Forecast Median Consensus

    The mean or average NAV / share forecast submitted by any analyst for the company.

    Definition of NAV / Share Forecast Median Consensus

    Hide this widget
    The mean or average NAV / share forecast submitted by any analyst for the company.

    Sector Benchmark Analysis

    Sector
    Industry Group
    Industry
    Hide this widget
    -47.64-7.6432.3695.282060100140

    The chart above depicts the distribution of nav / share forecast median consensus for companies operating in the Healthcare sector in the Developed economic region. Over 300 companies were considered in this analysis, and 297 had meaningful values. The average nav / share forecast median consensus of companies in the sector is 5.22 with a standard deviation of 17.73.

    Assertio Therapeutics Inc's NAV / Share Forecast Median Consensus of - ranks in the - percentile for the sector. The following table provides additional summary stats:

    NAV / Share Forecast Median Consensus In The Healthcare Sector
    Economic Risk RegionDeveloped
    Total Constituents309
    Included Constituents297
    Min-52.14
    Max88.24
    Median0.65
    Mean5.22
    Standard Deviation17.73

    You can find companies with similar nav / share forecast median consensus using this stock screener.

    All rights reserved. Terms Of Use